WVE

Healthcare Biotechnology

Wave Life Sciences, Inc.

$3.78

-0.09 -2.30% today

Price History

Not enough data

Key Stats

Market Cap

744.84M

Avg Volume

3.08M

EPS

-$1.08

52W High

$21.73

52W Low

$3.56

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-3.27

P/B Ratio

1.61

P/S Ratio

11.39

EV/EBITDA

-1.39

EV/Revenue

4.56

Margins

Gross Margin (202.0%)

Operating Margin (3248.3%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

(73.9%)

Return on Equity

(67.4%)

Return on Assets

(33.6%)

Liquidity & Leverage

Current Ratio

9.99

Quick Ratio

9.67

Debt / Equity

0.10

Total Cash

490.60M

Total Debt

43.59M

About

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.

wavelifesciences.com